New mexico alzheimer's disease research center

Active Project Grant Awarded Last action

Award ID
P30AG086404
Recipient
Awarding agency
Obligated
$26,629,419

Award facts

Assistance listing
93.866 Aging Research
Completion date 50% complete
Place of performance
Albuquerque, NM 87131, USA

Award details come from USAspending.gov.

Description

Abstract
Overall the new mexico alzheimer's disease research center (NM adrc) is strategically and geographically positioned in an area of the country with an extremely diverse and underserved population that has limited access to health and dementia care. With funding from the NIH for the prior P20 exploratory adrc, we established an infrastructure and formed partnerships to improve dementia care in rural communities of new mexico and provided them an opportunity to be part of the national network of adrc centers formed to meet the crisis in ad/adrd. The NM adrc is built on years of experience of research on biomarkers to identify vascular contributions to alzheimer's and inflammation. We have studied the impact of inflammation and blood-brain barrier (BBB) disruption as key mechanisms of disease. We have a strong track record of multi-consortium studies through RO1 and markvcid grants. This proposal for a NM adrc is to establish a fully integrated adrc in new mexico, a frontier state with a high proportion of minorities without access to dementia diagnosis and treatment. We plan to collaborate with other adrcs and identify novel risk factors driving dementia in underserved hispanic/latino (h/l) and american indian (AI) communities. We will work on-site in the remote areas, such as zuni and acoma pueblos, with the use of a mobile MRI scanner and community health representatives. The large hispanic/latino populations in the state will be engaged in the outreach, recruitment, and engagement (ORE) core. The UNM center for memory and aging uses biomarkers to change the way we diagnosis, classify and treat adults with cognitive impairment. The biomarker fluid core can test for biomarkers in plasma that will make large scale screening to identify patients at risk for ad/adrd in the rural population. The neuroimaging core can determine the presence of vascular disease by diffusion tensor imaging of white matter, and the biomarker core can measure proteins associated with inflammation and neurodegeneration in the blood, improving patient classification. Scientifically, the NM adrc will be at the cutting-edge in developing novel neuroimaging and fluid-based biomarkers that help distinguish different types of dementia at an early stage and accurately classify them for future clinical trials. New cores and components in the NM adrc for neuropathology, outreach, recruitment, and engagement, and research education will provide new mexico with expanded resources for dementia care, training, and research that will benefit ad researchers in the state. We plan to accomplish this under four specific overall aims: specific aim 1: recruit and retain a large cohort of older individuals with cognitive disabilities, particularly those in the medically underserved minority communities. Specific aim 2: improve classification of the heterogeneous dementia patient population with plasma-based biomarkers that have been developed as part of the nmeadrc and markvcid consortium. Specific aim 3: study the role of vascular disease and inflammation in the pathogenesis of ad and multi etiology dementia. Specific aim 4: train the next generation of healthcare workers from diverse h/l and AI communities.

Transactions

Action Obligated Date
Amendment $0
Amendment $4,358,782
Amendment $4,358,782
Amendment $0
Amendment $0
Amendment New mexico alzheimer's disease research center - the new mexico alzheimer's disease research center (NM adrc) is strategically and geographically positioned… $0
Amendment $96,505
Amendment $96,505
Amendment $96,505
Amendment $96,505
Amendment $4,367,886
Amendment $4,367,886
Amendment New mexico alzheimer's disease research center - the new mexico alzheimer's disease research center (NM adrc) is strategically and geographically positioned… $4,367,886
Original award $4,422,177
Show all 14

Subawards

Subrecipient Amount Awarded
Mind Research Network NeuroImaging Core Dr. Caprihan is the PI for the Neuroimaging Core of the UNM-ADRC. He will be responsible for overall MRI data collection and its analysis.… $1,535,863

Quick answers

Who received award P30AG086404?

P30AG086404 was awarded to University Of New Mexico by National Institute on Aging (National Institutes of Health) on May 1, 2024.

How much is award P30AG086404 worth?

$26,629,419 has been obligated on P30AG086404.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award